Synthesis of 2-chloropurine ribosides with chiral amino acid amides at C6 and their evaluation as A 1 adenosine receptor agonists
A series of purine ribonucleosides bearing chiral amino acid amides at the C6 position of 2-chloropurine was synthesized. Molecular docking of the synthesized analogs of 2-chloroadenosine by their affinity for A adenosine receptors (A ARs) was conducted. The investigation of A AR stimulating activit...
Gespeichert in:
Veröffentlicht in: | Bioorganic chemistry 2022-05, Vol.126, p.105878 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | 105878 |
container_title | Bioorganic chemistry |
container_volume | 126 |
creator | Berzina, Maria Ya Eletskaya, Barbara Z Kayushin, Alexei L Dorofeeva, Elena V Lutonina, Olga I Fateev, Ilya V Paramonov, Alexander S Kostromina, Maria A Zayats, Evgeniy A Abramchik, Yulia A Maltsev, Dmitriy V Naumenko, Ludmila V Taran, Alena S Yakovlev, Dmitry S Spasov, Alexander A Miroshnikov, Anatoly I Esipov, Roman S Konstantinova, Irina D |
description | A series of purine ribonucleosides bearing chiral amino acid amides at the C6 position of 2-chloropurine was synthesized. Molecular docking of the synthesized analogs of 2-chloroadenosine by their affinity for A
adenosine receptors (A
ARs) was conducted. The investigation of A
AR stimulating activity of synthesized nucleosides was carried out in a model of an isolated mouse atrium. We have shown that derivatives with tyrosine, valine, and serine residues exhibit the properties of A
AR partial agonists. Animal experiments in the open field test have shown that these compounds have different profiles of psychoactive action. These nucleosides have an ophthalmic hypotensive effect and reduce intraocular pressure in a manner slightly inferior to that of timolol and brimonidine. The synthesized nucleosides can be the basis for further design and synthesis of new A
AR agonists. |
doi_str_mv | 10.1016/j.bioorg.2022.105878 |
format | Article |
fullrecord | <record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmed_primary_35660725</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>35660725</sourcerecordid><originalsourceid>FETCH-pubmed_primary_356607253</originalsourceid><addsrcrecordid>eNqFjs1OwzAQhC0k1JafN0BoXyDBdpukHFEF4l7u1SZ2m60Sb-R1QD3y5iQSnDnNaGb0aZR6MDo32pRP57wm5njKrbZ2iopttb1SK6OfdWaN1Ut1I3LW2phNVS7Ucl2Upa5ssVLf-0tIrRcS4CPYrGk7jjyMkYKHSDULOS_wRamFpqWIHWBPgQEbcrOdW0ywKwGDgwlFEfwndiMm4gAo8AIG0PkwoWamb_yQOAKeOJAkuVPXR-zE3__qrXp8e_3YvWfDWPfeHYZIPcbL4e_z-t_BD1BCVOQ</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Synthesis of 2-chloropurine ribosides with chiral amino acid amides at C6 and their evaluation as A 1 adenosine receptor agonists</title><source>Elsevier ScienceDirect Journals</source><creator>Berzina, Maria Ya ; Eletskaya, Barbara Z ; Kayushin, Alexei L ; Dorofeeva, Elena V ; Lutonina, Olga I ; Fateev, Ilya V ; Paramonov, Alexander S ; Kostromina, Maria A ; Zayats, Evgeniy A ; Abramchik, Yulia A ; Maltsev, Dmitriy V ; Naumenko, Ludmila V ; Taran, Alena S ; Yakovlev, Dmitry S ; Spasov, Alexander A ; Miroshnikov, Anatoly I ; Esipov, Roman S ; Konstantinova, Irina D</creator><creatorcontrib>Berzina, Maria Ya ; Eletskaya, Barbara Z ; Kayushin, Alexei L ; Dorofeeva, Elena V ; Lutonina, Olga I ; Fateev, Ilya V ; Paramonov, Alexander S ; Kostromina, Maria A ; Zayats, Evgeniy A ; Abramchik, Yulia A ; Maltsev, Dmitriy V ; Naumenko, Ludmila V ; Taran, Alena S ; Yakovlev, Dmitry S ; Spasov, Alexander A ; Miroshnikov, Anatoly I ; Esipov, Roman S ; Konstantinova, Irina D</creatorcontrib><description>A series of purine ribonucleosides bearing chiral amino acid amides at the C6 position of 2-chloropurine was synthesized. Molecular docking of the synthesized analogs of 2-chloroadenosine by their affinity for A
adenosine receptors (A
ARs) was conducted. The investigation of A
AR stimulating activity of synthesized nucleosides was carried out in a model of an isolated mouse atrium. We have shown that derivatives with tyrosine, valine, and serine residues exhibit the properties of A
AR partial agonists. Animal experiments in the open field test have shown that these compounds have different profiles of psychoactive action. These nucleosides have an ophthalmic hypotensive effect and reduce intraocular pressure in a manner slightly inferior to that of timolol and brimonidine. The synthesized nucleosides can be the basis for further design and synthesis of new A
AR agonists.</description><identifier>EISSN: 1090-2120</identifier><identifier>DOI: 10.1016/j.bioorg.2022.105878</identifier><identifier>PMID: 35660725</identifier><language>eng</language><publisher>United States</publisher><ispartof>Bioorganic chemistry, 2022-05, Vol.126, p.105878</ispartof><rights>Copyright © 2022 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35660725$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Berzina, Maria Ya</creatorcontrib><creatorcontrib>Eletskaya, Barbara Z</creatorcontrib><creatorcontrib>Kayushin, Alexei L</creatorcontrib><creatorcontrib>Dorofeeva, Elena V</creatorcontrib><creatorcontrib>Lutonina, Olga I</creatorcontrib><creatorcontrib>Fateev, Ilya V</creatorcontrib><creatorcontrib>Paramonov, Alexander S</creatorcontrib><creatorcontrib>Kostromina, Maria A</creatorcontrib><creatorcontrib>Zayats, Evgeniy A</creatorcontrib><creatorcontrib>Abramchik, Yulia A</creatorcontrib><creatorcontrib>Maltsev, Dmitriy V</creatorcontrib><creatorcontrib>Naumenko, Ludmila V</creatorcontrib><creatorcontrib>Taran, Alena S</creatorcontrib><creatorcontrib>Yakovlev, Dmitry S</creatorcontrib><creatorcontrib>Spasov, Alexander A</creatorcontrib><creatorcontrib>Miroshnikov, Anatoly I</creatorcontrib><creatorcontrib>Esipov, Roman S</creatorcontrib><creatorcontrib>Konstantinova, Irina D</creatorcontrib><title>Synthesis of 2-chloropurine ribosides with chiral amino acid amides at C6 and their evaluation as A 1 adenosine receptor agonists</title><title>Bioorganic chemistry</title><addtitle>Bioorg Chem</addtitle><description>A series of purine ribonucleosides bearing chiral amino acid amides at the C6 position of 2-chloropurine was synthesized. Molecular docking of the synthesized analogs of 2-chloroadenosine by their affinity for A
adenosine receptors (A
ARs) was conducted. The investigation of A
AR stimulating activity of synthesized nucleosides was carried out in a model of an isolated mouse atrium. We have shown that derivatives with tyrosine, valine, and serine residues exhibit the properties of A
AR partial agonists. Animal experiments in the open field test have shown that these compounds have different profiles of psychoactive action. These nucleosides have an ophthalmic hypotensive effect and reduce intraocular pressure in a manner slightly inferior to that of timolol and brimonidine. The synthesized nucleosides can be the basis for further design and synthesis of new A
AR agonists.</description><issn>1090-2120</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNqFjs1OwzAQhC0k1JafN0BoXyDBdpukHFEF4l7u1SZ2m60Sb-R1QD3y5iQSnDnNaGb0aZR6MDo32pRP57wm5njKrbZ2iopttb1SK6OfdWaN1Ut1I3LW2phNVS7Ucl2Upa5ssVLf-0tIrRcS4CPYrGk7jjyMkYKHSDULOS_wRamFpqWIHWBPgQEbcrOdW0ywKwGDgwlFEfwndiMm4gAo8AIG0PkwoWamb_yQOAKeOJAkuVPXR-zE3__qrXp8e_3YvWfDWPfeHYZIPcbL4e_z-t_BD1BCVOQ</recordid><startdate>20220518</startdate><enddate>20220518</enddate><creator>Berzina, Maria Ya</creator><creator>Eletskaya, Barbara Z</creator><creator>Kayushin, Alexei L</creator><creator>Dorofeeva, Elena V</creator><creator>Lutonina, Olga I</creator><creator>Fateev, Ilya V</creator><creator>Paramonov, Alexander S</creator><creator>Kostromina, Maria A</creator><creator>Zayats, Evgeniy A</creator><creator>Abramchik, Yulia A</creator><creator>Maltsev, Dmitriy V</creator><creator>Naumenko, Ludmila V</creator><creator>Taran, Alena S</creator><creator>Yakovlev, Dmitry S</creator><creator>Spasov, Alexander A</creator><creator>Miroshnikov, Anatoly I</creator><creator>Esipov, Roman S</creator><creator>Konstantinova, Irina D</creator><scope>NPM</scope></search><sort><creationdate>20220518</creationdate><title>Synthesis of 2-chloropurine ribosides with chiral amino acid amides at C6 and their evaluation as A 1 adenosine receptor agonists</title><author>Berzina, Maria Ya ; Eletskaya, Barbara Z ; Kayushin, Alexei L ; Dorofeeva, Elena V ; Lutonina, Olga I ; Fateev, Ilya V ; Paramonov, Alexander S ; Kostromina, Maria A ; Zayats, Evgeniy A ; Abramchik, Yulia A ; Maltsev, Dmitriy V ; Naumenko, Ludmila V ; Taran, Alena S ; Yakovlev, Dmitry S ; Spasov, Alexander A ; Miroshnikov, Anatoly I ; Esipov, Roman S ; Konstantinova, Irina D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-pubmed_primary_356607253</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Berzina, Maria Ya</creatorcontrib><creatorcontrib>Eletskaya, Barbara Z</creatorcontrib><creatorcontrib>Kayushin, Alexei L</creatorcontrib><creatorcontrib>Dorofeeva, Elena V</creatorcontrib><creatorcontrib>Lutonina, Olga I</creatorcontrib><creatorcontrib>Fateev, Ilya V</creatorcontrib><creatorcontrib>Paramonov, Alexander S</creatorcontrib><creatorcontrib>Kostromina, Maria A</creatorcontrib><creatorcontrib>Zayats, Evgeniy A</creatorcontrib><creatorcontrib>Abramchik, Yulia A</creatorcontrib><creatorcontrib>Maltsev, Dmitriy V</creatorcontrib><creatorcontrib>Naumenko, Ludmila V</creatorcontrib><creatorcontrib>Taran, Alena S</creatorcontrib><creatorcontrib>Yakovlev, Dmitry S</creatorcontrib><creatorcontrib>Spasov, Alexander A</creatorcontrib><creatorcontrib>Miroshnikov, Anatoly I</creatorcontrib><creatorcontrib>Esipov, Roman S</creatorcontrib><creatorcontrib>Konstantinova, Irina D</creatorcontrib><collection>PubMed</collection><jtitle>Bioorganic chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Berzina, Maria Ya</au><au>Eletskaya, Barbara Z</au><au>Kayushin, Alexei L</au><au>Dorofeeva, Elena V</au><au>Lutonina, Olga I</au><au>Fateev, Ilya V</au><au>Paramonov, Alexander S</au><au>Kostromina, Maria A</au><au>Zayats, Evgeniy A</au><au>Abramchik, Yulia A</au><au>Maltsev, Dmitriy V</au><au>Naumenko, Ludmila V</au><au>Taran, Alena S</au><au>Yakovlev, Dmitry S</au><au>Spasov, Alexander A</au><au>Miroshnikov, Anatoly I</au><au>Esipov, Roman S</au><au>Konstantinova, Irina D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Synthesis of 2-chloropurine ribosides with chiral amino acid amides at C6 and their evaluation as A 1 adenosine receptor agonists</atitle><jtitle>Bioorganic chemistry</jtitle><addtitle>Bioorg Chem</addtitle><date>2022-05-18</date><risdate>2022</risdate><volume>126</volume><spage>105878</spage><pages>105878-</pages><eissn>1090-2120</eissn><abstract>A series of purine ribonucleosides bearing chiral amino acid amides at the C6 position of 2-chloropurine was synthesized. Molecular docking of the synthesized analogs of 2-chloroadenosine by their affinity for A
adenosine receptors (A
ARs) was conducted. The investigation of A
AR stimulating activity of synthesized nucleosides was carried out in a model of an isolated mouse atrium. We have shown that derivatives with tyrosine, valine, and serine residues exhibit the properties of A
AR partial agonists. Animal experiments in the open field test have shown that these compounds have different profiles of psychoactive action. These nucleosides have an ophthalmic hypotensive effect and reduce intraocular pressure in a manner slightly inferior to that of timolol and brimonidine. The synthesized nucleosides can be the basis for further design and synthesis of new A
AR agonists.</abstract><cop>United States</cop><pmid>35660725</pmid><doi>10.1016/j.bioorg.2022.105878</doi></addata></record> |
fulltext | fulltext |
identifier | EISSN: 1090-2120 |
ispartof | Bioorganic chemistry, 2022-05, Vol.126, p.105878 |
issn | 1090-2120 |
language | eng |
recordid | cdi_pubmed_primary_35660725 |
source | Elsevier ScienceDirect Journals |
title | Synthesis of 2-chloropurine ribosides with chiral amino acid amides at C6 and their evaluation as A 1 adenosine receptor agonists |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T23%3A04%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Synthesis%20of%202-chloropurine%20ribosides%20with%20chiral%20amino%20acid%20amides%20at%20C6%20and%20their%20evaluation%20as%20A%201%20adenosine%20receptor%20agonists&rft.jtitle=Bioorganic%20chemistry&rft.au=Berzina,%20Maria%20Ya&rft.date=2022-05-18&rft.volume=126&rft.spage=105878&rft.pages=105878-&rft.eissn=1090-2120&rft_id=info:doi/10.1016/j.bioorg.2022.105878&rft_dat=%3Cpubmed%3E35660725%3C/pubmed%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/35660725&rfr_iscdi=true |